97072 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Albumins Ovalbumin
GLYCOTARGETING THERAPEUTICS
#2NON-ANIMAL BASED PROTEIN SOURCES WITH FUNCTIONAL PROPERTIES
#3GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES
#4RECOMBINANTLY EXPRESSESD PROTEINS IN CHEMOAUTOTROPHIC MICROORGANISMS FOR USE AS FOOD INGREDIENTS
#5SINGLE-AND MULTI-EPITOPE PEPTIDE AND MRNA VACCINES TO GENERATE TOLEROGENIC EFFECTS FOR ALLERGIC AND AUTOIMMUNE DISEASE BY TARGETING LIVER SINUSOIDAL ENDOTHELIAL CELLS
#6SOLUBLE MULTIMERIC FUSION PROTEINS AND METHODS OF TREATMENT USING THE FUSION PROTEINS
#7ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER
#8TARGET MOLECULE REDUCTION METHOD, REDUCTION DEVICE, AND ELECTRODE
#9RECOMBINANT PROTEIN RECOVERY METHODS AND USES THEREOF
#10COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS
#11ERYTHROCYTE-BINDING THERAPEUTICS
#12Peptides And Methods For Detecting Egg Allergies
#13METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION
#14METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION
#15COMPOSITIONS, METHODS AND SYSTEMS FOR PRODUCTION OF EGG WHITE PROTEINS IN PLANTS
#16Exosome-targeted DNA vaccine
#17IMMUNOSUPPRESSANT IN COMBINATION WITH HIGH AFFINITY IL-2 RECEPTOR AGONISTS AND RELATED DOSING
#18T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#19SYNTHETIC EXPRESSION SYSTEMS
#20NON-ANIMAL BASED PROTEIN SOURCES WITH FUNCTIONAL PROPERTIES
#21Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof
#22EXPRESSION OF MODIFIED PROTEINS IN A PEROXISOME
#23METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION
#24GLYCOTARGETING THERAPEUTICS
#25COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS
#26Protein Separation
#27PROTEIN-BASED BIOMATERIAL WITH VISCOELASTIC BEHAVIOUR, PROCESS FOR OBTAINING IT AND USES THEREOF
#28PLANT CELL MATRICES AND METHODS THEREOF
#29TOXOPLASMA PLATFORM FOR TREATING CANCER
#30Exosome-targeted DNA vaccine
#31IN VITRO PRODUCTION OF HIGH AFFINITY MONOCLONAL ANTIBODIES
#32Non-integrative listeria-based vaccine and method for inducing antitumor immune response
#33Erythrocyte-binding therapeutics
#34Chromatography membranes, devices containing them, and methods of use thereof
#35Triblock peptide amphiphiles, micelles and methods of use
#36RECOMBINANT YEAST AS ANIMAL FEED
#37Recombinant animal-free food compositions and methods of making them
#38Glycotargeting therapeutics
#39Erythrocyte-binding therapeutics
#40Phage conjugates and uses thereof
#41EXOSOME-TARGETED DNA VACCINE
#42T-cell modulatory multimeric polypeptides and methods of use thereof
#43Chromatography membranes, devices containing them, and methods of use thereof
#44Methods and compositions for egg white protein production
#45Glycotargeting therapeutics
#46Immune tolerant and non-immune tolerant elastin-like recombinant peptides and methods of use
#47Laser-assisted intradermal administration of active substances
#48Compositions and methods for enhancing an immune response
#49Recombinant Bacterium and Uses Thereof
#50Chromatography membranes, devices containing them, and methods of use thereof
#51Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#52Erythrocyte-binding therapeutics
#53Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex
#54Separation matrices for purification of biological particles
#55A METHOD FOR PRODUCING NANOSTRUCTURED OR MICROSTRUCTURED MATERIALS AND A DEVICE FOR THEIR PRODUCTION
#56Vault immunotherapy
#57Adjuvant for mucosal vaccine
#58Biochemical markers for CVD risk assessment
#59AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTIN
#60METHOD FOR PREPARING LOW ANTIGENIC FOOD AND LOW ANTIGENIC FOOD PREPARED BY SAID METHOD
#61COMPOSITIONS AND METHODS FOR TREATING IMMUNE CONDITIONS, INCLUDING TYPE 1 DIABETES
#62Compositions and methods
#63Cell penetrating peptides
#64Selective binding of biological targets to solid phase ureides
#65Method of purifying/concentrating sugar chains with a sugar chain-trapping molecule and method of analyzing sugar chain structure
#66Immunogenic composition and uses thereof
#67Vault Immunotherapy
#68Recombinant bacterium and uses thereof
#69Methods for treating diseases with peptides that inhibit IGF-1
#70ISOLATED EGG PROTEIN AND EGG LIPID MATERIALS, AND METHODS FOR PRODUCING THE SAME
#71Targeted Delivery Of Autoantigens To B Cell Populations
#72PLATE WITH TITANIUM DIOXIDE ON ITS SURFACE, MANUFACTURING PROCESS AND USES THEREOF
#73Nanoparticle-peptide compositions
#74Haptens of paliperidone
#75Haptens of olanzapine
#76Pyrenyloxysulfonic acid fluorescent agents
#77Isolated egg protein and egg lipid materials, and methods for producing the same
#78Bioactive peptide
#79Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allengenic diseases
#80Fraction of Proteins and Peptides Derived from Egg White and Protein Derived From Egg White and Use Thereof as Anti Listeria Agent
#81DELIVERY PROTEINS
#82Pyrenyloxysulfonic acid fluorescent agents
#83Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#84Multi-epitopic vaccine
#85Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1
#86TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#87IMMUNOGENIC COMPOSITION AND USES THEREOF
#88Pyrenyloxysulfonic acid fluorescent agents
#89Erythrocyte-binding therapeutics
#90Biochemical markers for CVD risk assessment
#91Positive control proteins for glucose transporter proteins and processes for the generation of such positive control proteins
#92Chromatography Membranes, Devices Containing Them, and Methods of Use Thereof
#93Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#94TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#95Methods for Determining the Cleavability of Substrates
#96Agents and methods based on the use of the EDA domain of fibronectin
#97USE OF RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) FOR THE TREATMENT OF TYPE 1 HYPERSENSITIVITY IN A LIVING ANIMAL INCLUDING HUMANS
#98Methods for isolation and analysis of sialylated and phosphorylated peptides
#99Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same
#100VACCINE COMPOSITION CONTAINING IRRADIATED OVALBUMIN FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE
#101Pyrenyloxysulfonic acid fluorescent agents
#102Photoactivatable composition and uses thereof
#103Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure
#104Avians that produce eggs containing exogenous proteins
#105Production of exogenous proteins in egg whites of transgenic chickens
#106Photoactivatable composition and uses thereof
#107Method of producing an exogenous protein in the egg of a chicken
#108Transgenic chickens producing exogenous protein in eggs
#109Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#110Trans-membrane-antibody induced inhibition of apoptosis